Predicting chemotherapy toxicity in elderly patients with non small cell lung cancer

Predicting chemotherapy toxicity in elderly patients with non small cell lung cancer - Predicting elderly patients' vulnerability for chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010384

Enrollment

350

Registered

2013-04-01

Start date

2013-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligibility criteria are as follows: (1) pathologically proven non-small cell lung cancer adaptable to chemotherapy; (2)chemotherapy naive patients inadequate for operation and radiation therapy; (3) patients with aged 70 and over; (4) written informed consent.

Exclusion criteria

Exclusion criteria: Exclusin criteria are as follows: (1) patients with active other cancers; (2) patients treated with chemotherapy; (3)patients who needs thoracic radiotherapy; (4) patients who have pleural effusion with poor control; (5) Unsuitable cases are whom doctors jugde unable to be carried out this research safely, and who have severe dementia.

Design outcomes

Primary

Measure	Time frame
Assessment for elderly patients; vulnerability for chemotherapy and incidence of toxicity	—

Secondary

Measure	Time frame
Assessment for compliance of chemotherapy, response rate and overall survival	—

Countries

Japan

Contacts

Public ContactMasaki Kanazu

National Hospital Organization Toneyama Hospital Department of Internal Medicine

kanamasa@toneyama.go.jp06-6853-2001

Outcome results